HES5 and hepatocellular carcinoma: Treatment of HCC cells with the γ‐secretase inhibitor, DBZ, did not affect the expression of active ADAM10 but fully eradicated the expressions of NICD1 and Hes5 enhanced by Tspan5 in HCC cells.